Skip to content
Finance Investment, Oil Mining Resources

Elevate Uranium Limited (ASX:EL8) – Koppies Inferred Resource Drilling Completed

Elevate Uranium Limited (ASX:EL8) 2 mins read

PERTH, Australia – Elevate Uranium Limited (ASX:EL8) (OTCQX:ELVUF), an ASX listed uranium exploration company, is excited to announce significant advancements in its Koppies project, including the completion of its inferred resource drilling programs. These developments mark a pivotal step towards updating the current 48 Mlb eU3O8 Inferred JORC Mineral Resource Estimate (MRE) for Koppies, with a new MRE expected to be released by early April.

The company has initiated an infill drilling program aimed at upgrading the JORC category of the Koppies project from Inferred to Indicated. This strategic move underscores Elevate Uranium's commitment to transitioning from resource growth to project advancement.

Murray Hill, Managing Director of Elevate Uranium, expressed his enthusiasm about the project's progress, stating, "The Company is transitioning its focus at Koppies from resource growth to project advancement by increasing the JORC resource category from Inferred to Indicated, which will then feed into a scoping study and provide metrics on the project. Data from the latest phase of the resource growth drilling is being processed and the updated resource estimation is in progress. The updated JORC Inferred resource is expected to be released by early April. The Company considers the Koppies resource to be of sufficient size to take to the next level of development and as such three drill rigs are currently working on the infill JORC Indicated drilling program. Metallurgical samples are planned to be collected in April/May for an advanced metallurgical testwork program utilising the Company’s proprietary U-pgradeTM beneficiation process."

In preparation for a comprehensive scoping study scheduled to commence in late 2024, Elevate Uranium is prioritizing the increase of the Koppies mineral resource to a majority JORC Indicated resource category. This effort is crucial for the publication of an economic study on the project.

The upcoming metallurgical testwork, set to begin after the collection of samples in April/May, will employ the Company's proprietary U-pgradeTM beneficiation process. This testwork is essential for understanding the metallurgical characteristics of the Koppies ore and will contribute valuable data for the initial design of the mining and process flowsheet.

Elevate Uranium is dedicated to advancing the Koppies project through these strategic developments, aiming to unlock the project's full potential and deliver value to its stakeholders.


Contact details:

Jane Morgan

[email protected]

Media

More from this category

  • Finance Investment
  • 13/01/2026
  • 13:40
Moomoo

Focused on AI, Australian investors expect 2026 to deliver

SYDNEY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Australian investors have started the new year with an overwhelming appetite for artificial intelligence and expectations of solid returns from their increasingly global portfolios, a comprehensive new survey by stock broking firm Moomoo Australia and New Zealand reveals.The detailed survey of more than 600 Australian investors' expectations and intentions for the year complements the release of moomoo's 2026 Market Outlook today, where our local experts and global research team analyse key trends in financial markets for the year ahead.And this year, investors are committing to high-growth sectors, including AI – showing a willingness…

  • Finance Investment, Oil Mining Resources
  • 13/01/2026
  • 10:22
Jane Morgan Management

Patriot Resources reports significant silver and gold results validating Kitumba polymetallic target in Zambia

Perth, Australia – 13 January 2026: Patriot Resources Limited (ASX: PAT) has reported significant silver and gold assay results from its Phase 1 trenching program at Target B1 within the Company’s 80%-owned Kitumba 27715 Project in Zambia, further validating the prospect as a near-surface polymetallic system. The latest results add silver and gold credits to previously announced strong copper, zinc and lead geochemistry, reinforcing the scale and potential economic significance of the mineralised system. The Company said the combination of metals highlights a unique polymetallic signature and strengthens confidence in Target B1 as a priority focus for ongoing exploration. Notable…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.